Posted on 1/26/21
Rogers Hall (Lowell) Holds COVID Vaccine Clinic for Residents
Peabody Properties recently coordinated a COVID vaccine clinic for the residents of Rogers Hall in Lowell, in partnership with CVS. The clinic was a huge success, . . .
Posted on 1/26/21
Chelsea Village Residents Receive COVID Vaccine
Chelsea Village Elderly held one of the very first COVID Vaccine Clinics for Peabody Properties on Tuesday, January 12, 2021. Staff and over 100 residents were . . .
Posted on 1/26/21
Nirogy Therapeutics Closes $16.5 Million Series A Financing
Nirogy Therapeutics Inc., a privately-held biotechnology company developing novel small molecules to target cellular transporters, today announced the closing of a $16.5 million Series A financing.
Posted on 1/26/21
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
With the U.S. starting to open up more but a full reopening only possible once we achieve widespread vaccination, the personal-finance website WalletHub today released updated . . .
Posted on 1/26/21
Is Moderna a Smart Pick for Long-Term Investors?
There's no question that Moderna (NASDAQ:MRNA) has been a big winner for investors. The biotech stock skyrocketed 434% in 2020. But can the company keep the . . .
Posted on 1/26/21
Moderna Says Vaccine Protects Against All Known Variants
Moderna (NASDAQ:MRNA) announced evidence that its COVID-19 vaccine is protective against all variants of the SARS-CoV-2 virus detected to date, including two strains first detected in . . .
Posted on 1/26/21
Phio Pharmaceuticals Closes $14M Private Placement
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 1/25/21
East Boston Neighborhood Health Center Expands Pediatric Practice at South End Community Health Center
Caroline Castleforte, M.D. brings more than 14 years of experience to new roleAs part of its recent expansion into the South End, East Boston Neighborhood Health . . .
Posted on 1/25/21
TScan Therapeutics Closes $100 Million Series C Financing
TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies in oncology, today announced the closing of an oversubscribed . . .
Posted on 1/25/21
Is CVS Health a Great Dividend Stock?
CVS Health (NYSE:CVS) is the nation's largest chain pharmacy retailer, with control of nearly 25% of the market. It also has the reputation as a solid . . .
Posted on 1/25/21
Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg
Investors have been excited for quite a while now about Moderna's (NASDAQ:MRNA) COVID-19 vaccine, mRNA-1273. And for good reason. Moderna stands to make billions of dollars . . .
Posted on 1/25/21
Could Moderna Be a Millionaire-Maker Stock?
If you had bought shares of Moderna (NASDAQ:MRNA) in January 2020, you would be sitting pretty right now. Thanks to its coronavirus-related efforts, shares of the . . .
Posted on 1/25/21
What Are Moderna's Risks?
Moderna (NASDAQ:MRNA) is a high-flying biotech stock with a big year ahead of it. The company should make billions of dollars in 2021 from sales of . . .
Posted on 1/25/21
Fulcrum Therapeutics Closes Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically . . .
Posted on 1/22/21
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug . . .
Posted on 1/22/21
Senseonics Holdings Announces $50M Bought Deal Offering of Common Stock
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) . . .
Posted on 1/22/21
NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the closing of its previously announced private placement of an aggregate 2,500,000 shares of its . . .
Posted on 1/22/21
Phio Pharmaceuticals Announces $14.0 Million Private Placement
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 1/21/21
Boston Scientific To Acquire Preventice Solutions
Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full . . .
Posted on 1/21/21
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
WINDSOR, Conn.--(BUSINESS WIRE)--SCA Pharmaceuticals, LLC, has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Partners.The Vistria Group and Excellere Partners have . . .
Posted on 1/21/21
Bridges Consumer Healthcare Portfolio Company of Charlesbank Capital Partners Acquires Clarion Brands from Swander Pace Capital
CHATTANOOGA, Tenn., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Bridges Consumer Healthcare LLC has announced the acquisition of Clarion Brands, LLC, from Swander Pace Capital, adding to its . . .
Posted on 1/21/21
Moderna Investigating Reports of Allergic Reactions to Its Coronavirus Vaccine
Moderna (NASDAQ:MRNA) said on Tuesday that it was investigating a few cases in which patients appeared to have allergic reactions to its coronavirus vaccine. All of . . .
Posted on 1/21/21
Editas Medicine Prices of Offering of Common Stock
CAMBRIDGE, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced the pricing of an underwritten offering . . .
Posted on 1/20/21
Haemonetics To Acquire Cardiva Medical
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered . . .
Posted on 1/20/21
Aldeyra Therapeutics Closes of Public Offering of Common Stock
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives . . .
Boston
